Living with bipolar disorder

References

• Suppes T, Leverich GS, Keck PE et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J. Affect. Disord. 67, 45–59 (2001).
   Google Scholar
• Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J. Clin. Psychiatry 64, 161–174 (2003).
   Google Scholar
• Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-Depressive Association (NMDA) survey of bipolar members. J. Affect. Disord. 31, 281–294 (1994).
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J, Floris G. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord. 1, 91–97 (1999).
   Google Scholar
• Robb JC, Cooke RG, Devins GM et al. Quality of life and lifestyle disruption in euthymic bipolar disorder. J. Psychiatry Res. 31, 509–517 (1997).
   Google Scholar
• Dalton EJ, Carter TD, Mundo E et al. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord. 5, 58–61 (2003).
   Google Scholar
• Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Genet. Psychiatry 59, 530–537 (2002).
   Google Scholar
• Calabrese JR, Hirschfeld RM, Reed M et al. Impact of bipolar disorder on a US community sample. J. Clin. Psychiatry 64, 425–432 (2003).
   Google Scholar
• Hirschfeld RM, Williams JB, Spitzer RL et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry 157, 1873–1875 (2000).
   Google Scholar
• Morselli PL, Elgie R. GAMIAN-Europe/BEAM survey I. Global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 5, 265–278 (2003).
   Google Scholar
• Vojta C, Kinosian B, Glick H et al. Self-reported quality of life across mood states in bipolar disorder. Compr. Psychiatry 42, 190–195 (2001).
   Google Scholar
• Rubinsztein JS, Michael A, Paykel ES et al. Cognitive impairment in remission in bipolar affective disorder. Psychol. Med. 30, 1025–1036 (2000).
   Google Scholar
• Denicoff KD, Ali SO, Mirsky AF et al. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J. Affect. Disord. 56, 67–73 (1999).
   Google Scholar
• Zubieta JK, Huguelet P, O’Neil RL et al. Cognitive function in euthymic bipolar I disorder. Psychiatry Res. 102, 9–20 (2001).
   Google Scholar
• Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press (1990).
   Google Scholar
• Hirschfeld RMA, Clayton PJ, Cohen I et al. Practice guideline for the treatment of patients with bipolar disorder. Am. J. Psychiatry 51(Suppl. 12), 1–36 (1994).
   Google Scholar
• Keck PE, McElroy SL, Strakowski SM et al. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol. Bull. 3, 87–91 (1997).
   Google Scholar
• Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J. Clin. Psychiatry 63, 985–991 (2002).
   Google Scholar
• Franchini L, Zanardi R, Smeraldi E et al. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur. Arch. Psychiatry Clin. Neurosci. 249, 227–230 (1999).
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry 60(Suppl. 2), 77–84 (1999).
   Google Scholar
• Kasper S. Issues in the treatment of bipolar disorder. Eur. Neuropsychopharmacol. 13(Suppl. 2), S37–S42 (2003).
   Google Scholar
• McElroy SL, Keck Jr, PE. Pharmacological agents for the treatment of acute bipolar mania. Biol. Psychiatry 48, 539–557 (2000).
   Google Scholar
• Nemeroff CB. An ever-increasing Pharmacopeia for the management of patients with bipolar disorder. J. Clin. Psychiatry 61(Suppl. 13), 19–25 (2000).
   Google Scholar
• Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol. Psychiatry 48, 558–572 (2000).
   Google Scholar
• Gyulai L, Bowden CL, McElroy SL et al. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 28, 1374–1382 (2003).
   Google Scholar
• Revicki DA, Paramore LC, Sommerville KW et al. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical costs outcomes. J. Clin. Psychiatry 64, 288–294 (2003).
   Google Scholar
• Post RM. Mood disorders: treatment of bipolar disorders. In: Kaplan and Sadocks Comprehensive Textbook of Psychiatry, Seventh Edition. Sadock BJ, Sadock VA (Eds). Williams & Wilkins, NY, USA 1385–1430 (2000).
   Google Scholar
• Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Genet. Psychiatry 60, 392–400 (2003).
   Google Scholar
• Calabrese JR, Bowden CL, Sachs G et al.; Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64, 1013–1024 (2003).
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in out-patients with bipolar I depression. Lamictal 602 Study Group. J. Clin. Psychiatry 60, 79–88 (1999).
   Google Scholar
• Namjoshi MA, Rajamannar G, Jacobs T et al. Economic, clinical, and quality of life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. J. Affect. Disord. 69, 109–118 (2002).
   Google Scholar
• Shi L, Namjoshi MA, Zhang F et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int. Clin. Psychopharmacol. 17, 227–237 (2002).
   Google Scholar
• Kasper S, Stamenkovic M, Letmaier M, Schreinzer D. Atypical antipsychotics in mood disorders. Int. Clin. Psychopharmacol. 17(Suppl. 3), S1–10 (2002).
   Google Scholar
• Kasper S, Attarbaschi T. Treatment options for bipolar mania. Clin. Approach Bipolar Disord. 3, 24–32 (2003).
   Google Scholar
• Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Genet. Psychiatry 60, 1079–1088 (2003).
   Google Scholar
• Calabrese J, Macfadden W, McCoy R, Minkwitz M, Wilson E, Mullen J. Double-blind, placebo-controlled study of quetiapine in bipolar depression. 157th Annual Meeting of the American Psychiatric Association. NY, USA. 1–6th May (2004).
   Google Scholar
• Kusumaker V. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder. J. Clin. Psychiatry 63(Suppl. 10), 23–28 (2002).
   Google Scholar
• Sachs G, Chengappa KNR, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 6, 213–223 (2004).
   Google Scholar
• Jones M, Huizar K. Quetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2). Bipolar Disord. 5, 57 (2003) (Abstract P95).
   Google Scholar
• White RE. Antipsychotic compliance evaluation. Int. J. Neuropsychopharmacol. 5(Suppl. 1), S120 (2002) (Abstract).
   Google Scholar
• Namjoshi MA et al. A review of health-related quality of life literature in bipolar disorder. J. Affect. Disord. 69, 109–118 (2002).
   Google Scholar
• Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J. Clin. Psychiatry 61, 804–808 (2000).
   Google Scholar
• Möller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur. Arch. Psychiatry Clin. Neurosci. 250, 57–68 (2000).
   Google Scholar
• Kasper S. Bipolar disorder: a new field for rational polypharmacy. In: Bipolar Disorder. Evidence and Experience in Psychiatry. Maj M (Ed.) Wiley & Sons Ltd, Chichester, UK 275–276 (2002).
   Google Scholar
• Kasper S, Tauscher J, Aschauer H et al. Bipolare Störungen. Medikamentöse Therapie. Konsensus. Statement – State of the Art 2003. Clin. Cum. Psy. Sonderausgabe (2003).
   Google Scholar
• Craighead WE, Miklowitz DJ. Psychosocial interventions for bipolar disorder. J. Clin. Psychiatry 61(Suppl. 13), 58–64 (2000).
   Google Scholar
• Kasper S, Zohar J. Pharmacotherapy of bipolar depression. In: Decision Making in Psychopharmacology. Kasper S, Zohar J, Stein DJ (Eds) Martin Dunitz, London, UK, 13–23 (2002).
   Google Scholar
• Dogan S, Sabanciogullari S. The effects of patient education in lithium therapy on quality of life and compliance. Arch. Psychiatry Nurs. 17, 270–275 (2003).
   Google Scholar
• Patelis-Siotis I. Cognitive-behavioral therapy: applications for the management of bipolar disorder. Bipolar Disord. 3, 1–10 (2001).
   Google Scholar
• Miklovitz DJ, Richards JA, George EL et al. Integrated family and individual therapy for bipolar disorder: results of a treatment development study. J. Clin. Psychiatry 64, 182–191 (2003).
   Google Scholar
• Colom F, Vieta E, Reinares M, Martinez-Aran A, Torrent C, Goikolea JM, Gasto C. Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. J. Clin. Psychiatry 64, 1101–1105 (2003).
   Google Scholar